Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
ENDPOINTS NEWS
21h
Danish biotech Gubra touts early weight loss data in hot amylin field
The amylin field is heating up ahead of Novo Nordisk's much-anticipated CagriSema readout later this year. On Wednesday, ...
FierceBiotech
22h
Gura's weekly amylin obesity asset well tolerated, tied to weight loss in phase 1 trial
GUBamy is part of the investigational amylin field, a burgeoning landscape that includes Novo Nordisk’s CagriSema, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
The Onion buys Infowars
Republicans win the House
Declines WH invitation
Gaetz resigns from Congress
FBI raids Coplan's home
Remains ID'd after 82 years
Ban on executives upheld
Teen guilty of swatting calls
Threatened by LSU student?
Lawyers seek to quit case
Briefly detained at airport
Largest coral ever recorded
Pulled from lunch program
Reveals cancer diagnosis
Former solicitor general dies
Freevee to shut down
Starts issuing layoff notices
Gabbard picked as DNI
Israel accused of war crimes
US strikes Iran-linked group
Recalling pickups, SUVs
Wins GOP nod for speaker
Russia attacks Kyiv
Bitcoin rises above $90K
2,400+ Cybertrucks recalled
Trump, Biden meet at WH
To face US antitrust trial
China hacked telecom firms
Notre Dame set to reopen
US missile base in Poland
Related topics
Ozempic
Novo Nordisk
Wegovy
Feedback